Lung Cancer in the News

Read about the latest developments in the world of lung cancer. You'll find articles from the last 24 months.

April 2019

March 2019

February 2019

January 2019

December 2018

November 2018

October 2018

October 24, 2018: SBRT found to be safe treatment for patients with multiple metastases (News Medical Life Sciences)
October 19, 2018: Plasma NGS Should Be Routine in Metastatic NSCLC, Say Researchers (Cancer Therapy Advisor)

September 2018

August 2018

August 21, 2018: FDA OKs Expanded Keytruda Indication for Non-Small Cell Lung Cancer (Specialty Pharmacy Times)
August 20, 2018: FDA Approves Nivolumab for Small Cell Lung Cancer (Rare Disease Report)

July 2018

July 26, 2018: Takeda’s Alunbrig improves PFS in phase 3 lung cancer trial (Pharmaceutical Business Review)

June 2018

June 28, 2018: $20 M secured for federally-funded lung cancer research (Lung Cancer Alliance)

May 2018

April 2018

March 2018

February 2018

January 2018

December 2017

November 2017

October 2017

September 2017

September 26, 2017: Dacomitinib Improves PFS vs. Gefitinib in Non-Small Cell Lung Cancer (Cancer Therapy Advisor)
September 6, 2017: Adoptive Cellular Immunotherapy Improves Survival in Resected NSCLC (Cancer Therapy Advisor)
September 6, 2017: Alectinib: ALEX and ALUR Trials Show CNS Benefit in NSCLC (Medical Xpress)

August 2017

August 31, 2017: VA to Increase Access to Safe and Effective Lung Screening Programs (U.S. Department of Veterans Affairs)
August 23, 2017: Everolimus Maintains Quality of Life in Neuroendocrine Tumors (Cancer Therapy Advisor)

July 2017

June 2017

June 21, 2017: Once-Daily Radiotherapy Not Superior to Twice-Daily in SCLC (Cancer Therapy Advisor)
June 6, 2017: Studies Explore Targeted Therapies in Lung Cancer (ASCO Daily News)

May 2017

May 22, 2017: ASCO Report: Gefitinib beats Chemo After Surgery in NSCLC (Clinical Oncology News)

April 2017

March 2017

February 2017

February 27, 2017: Nasal swab could help diagnose lung cancer (Medical News Today)
February 27, 2017: No Benefit from Statin Use in Small Cell Lung Cancer (MedPage Today)
February 27, 2017: Long-Term NSCLC Survival Could Be 25% With Pembrolizumab (Oncology Nursing News)
February 22, 2017: Efficacy of Osimertinib in Advanced T790M-positive NSCLC (Cancer Therapy Advisor)
February 10, 2017: NSCLC: No Overall Survival Difference Between Afatinib and Gefitinib (Cancer Therapy Advisor)